Loading...

Johnson & Johnson

JNJNYSE
Healthcare
Drug Manufacturers - General
$170.74
$-0.30(-0.18%)

Johnson & Johnson (JNJ) Stock Overview

Explore Johnson & Johnson’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 78.0/100

Key Financials

Market Cap411.2B
P/E Ratio18.19
EPS (TTM)$9.34
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Week$155.47
1 Month$156.33
3 Months$159.49
1 Year Target$151.07

JNJ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Johnson & Johnson (JNJ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $151.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.19 and a market capitalization of 411.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;